WASHINGTON — Two manufacturers of the abortion pill mifepristone rushed to the Supreme Court on Saturday seeking emergency relief after a federal appeals court issued a sweeping ruling the day before that cut off mail-order access to the drug — a decision legal experts say represents the most significant disruption to abortion care in the United States since the fall of Roe v. Wade.
Danco Laboratories asked the high court for an emergency pause on the 5th U.S. Circuit Court of Appeals decision, saying the appellate ruling "injects immediate confusion and upheaval into highly time-sensitive medical decisions." GenBioPro, which makes a generic version of mifepristone, made a similar request.
